Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03319459 |
| Title | FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Fate Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCSD Moores Cancer Center | San Diego | California | 92037 | United States | Details | |
| University of Minnesota | Minneapolis | Minnesota | 55455 | United States | Details | |
| The Ohio State University James Cancer Hospital | Columbus | Ohio | 43210 | United States | Details | |
| Baylor Scott & White Research Institute | Dallas | Texas | 75246 | United States | Details |